Home

Hologic, Inc. - Common Stock (HOLX)

72.14
-0.03 (-0.04%)

Hologic Inc. is a global medical technology company focused on improving women's health through the development and delivery of innovative products and solutions

The company specializes in diagnostic, surgical, and medical imaging systems, with a particular emphasis on breast health, cervical health, and skeletal health. Hologic's offerings include advanced molecular diagnostics, imaging systems for breast cancer detection, and various surgical instruments and techniques that enhance patient care. With a commitment to advancing health outcomes for women, Hologic actively invests in research and development to address unmet medical needs and improve access to vital healthcare solutions.

SummaryNewsPress ReleasesChartHistoricalFAQ
Friday's pre-market session: top gainers and losers in the S&P500 indexchartmill.com
Get insights into the top gainers and losers in the S&P500 index of Friday's pre-market session.
Via Chartmill · January 31, 2025
5 S&P 500 Stocks Set To Shine In The Final Week Of January — If History Repeats Itselfbenzinga.com
S&P 500 surges to record highs in final week of January as investors react to economic optimism, Trump's leadership, and AI investments.
Via Benzinga · January 23, 2025
How Is The Market Feeling About Hologic?benzinga.com
Via Benzinga · January 23, 2025
FDA Warns Hologic Over BioZorb Manufacturing Violationsbenzinga.com
FDA issues warning to Hologic, citing manufacturing and safety violations for BioZorb devices. Patient safety risks and reporting failures highlighted
Via Benzinga · January 17, 2025
Peering Into Hologic's Recent Short Interestbenzinga.com
Via Benzinga · December 18, 2024
Expert Ratings For Hologicbenzinga.com
Via Benzinga · December 10, 2024
Peering Into Hologic's Recent Short Interestbenzinga.com
Via Benzinga · November 27, 2024
Looking Into Hologic's Recent Short Interestbenzinga.com
Via Benzinga · November 6, 2024
This James Hardie Industries Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesdaybenzinga.com
Via Benzinga · December 10, 2024
Wall Street Struggles Ahead Of Election Day, Energy Sector Outperforms, Solar Stocks Rise: What's Driving Markets Monday?benzinga.com
The U.S. stock market struggled to gain momentum on Monday as investors remained cautious ahead of Election Day on Tuesday.
Via Benzinga · November 4, 2024
Hologic Recalls Soft Tissue Marker Device BioZorb, FDA Issues Warning After Almost 400 Complaintsbenzinga.com
FDA and Hologic advise health providers to return all unused BioZorb Markers due to adverse events, including pain and infection.
Via Benzinga · October 25, 2024
Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatmentsbenzinga.com
Hologic Inc. is acquiring Gynesonics for $350 million, adding the Sonata System to its fibroid treatment lineup. The acquisition aims to boost Hologic's women's health offerings and expand minimally invasive solutions.
Via Benzinga · October 14, 2024
Assessing Hologic: Insights From 10 Financial Analystsbenzinga.com
Via Benzinga · October 4, 2024
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,600 Todaybenzinga.com
Via Benzinga · September 30, 2024
Critical Insights From Hologic Analyst Ratings: What You Need To Knowbenzinga.com
Via Benzinga · September 17, 2024
Here's How Much You Would Have Made Owning Hologic Stock In The Last 20 Yearsbenzinga.com
Via Benzinga · September 12, 2024
Peering Into Hologic's Recent Short Interestbenzinga.com
Via Benzinga · September 2, 2024
Here's How Much You Would Have Made Owning Hologic Stock In The Last 10 Yearsbenzinga.com
Via Benzinga · August 19, 2024
Analyst Scoreboard: 8 Ratings For Hologicbenzinga.com
Via Benzinga · August 16, 2024
$1000 Invested In This Stock 10 Years Ago Would Be Worth $3,200 Todaybenzinga.com
Via Benzinga · August 6, 2024
GE Aerospace To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Tuesdaybenzinga.com
Via Benzinga · July 30, 2024
Hologic Analysts Boost Their Forecasts After Q3 Resultsbenzinga.com
Via Benzinga · July 30, 2024
The Analyst Verdict: Hologic In The Eyes Of 8 Expertsbenzinga.com
Via Benzinga · July 30, 2024
Tech Stocks Drop Ahead Of Key Earnings; Nvidia Falls, CrowdStrike Hits 8-Month Low: What's Driving Markets Tuesday?benzinga.com
Investor sentiment took a hit on Tuesday as caution prevailed ahead of significant market events, including key tech earnings reports and the Federal Open Market Committee meeting.
Via Benzinga · July 30, 2024
HOLX Stock Earnings: Hologic Beats EPS, Beats Revenue for Q3 2024investorplace.com
HOLX stock results show that Hologic beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.
Via InvestorPlace · July 29, 2024